 |
April 14, 2025 |
|
Dear Advocate,
With the collapse in support from the US Presidential administration in global health, data sources tracking the HIV response have been lost, from HIV incidence and prevalence to PrEP uptake and disparities among key populations and regions of the world. Below, AVAC has identified dashboards, data trackers and other resources to inform your advocacy.
|
 |
Impact of the Stop-Work Order on PrEP
On PrEPWatch, this webpage outlines the consequences of PEPFAR stop-work orders on HIV prevention, detailing disruptions to PrEP services, stalled product rollouts (including CAB), halted research, and workforce reductions. It includes downloadable slides to support advocacy and analysis.

|
 |
Tracking Lenacapavir Rollout
This new online tracker monitors all the key steps, timelines and responsible stakeholders needed to ensure equitable access to injectable lenacapavir (LEN) for PrEP. Find it on PrEPWatch.

|
Tracking the Impact of USG Funding Cuts |
|
 |
Tracking the Freeze: Real-Time Impact on Key Populations
|
 |
PEPFAR Funding Freeze
This webpage shares resources developed by a new global civil society coalition, Community Health and HIV Advocates Navigating Global Emergencies (CHANGE) on various impacts of the freeze.
|
 |
Impact of Partial PEPFAR Funding Freeze and Discontinuation: Estimated Deaths
|
 |
Impact of US Funding Cuts on the Global AIDS Response
|
 |
The Best Investment You Didn’t Know You Made
|
 |
HIV Market Impact Memo
|
 |
The USAID List of Terminated Global Health Awards – What Does it Tell Us?
|
 |
Litigation Tracker: Legal Challenges to Trump Administration Actions
|
 |
AVAC V. United States Department of State
|
These trackers and additional resources are included in our weekly Global Health Watch newsletter along with the latest policy developments and their implications to keep advocates informed, prepared and connected.
|
|
|
You're receiving this because you signed up for our newsletter. Not interested any longer?
Manage email preferences | Unsubscribe
|
|
|